Global Insulin Dosing Device Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Insulin Dosing Device Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Insulin Dosing Device by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Insulin Dosing Device by Country/Region, 2017, 2022 & 2028

2.2 Insulin Dosing Device Segment by Type

2.2.1 Insulin Pens

2.2.2 Insulin Pumps

2.2.3 Insulin Syringes

2.2.4 Others

2.3 Insulin Dosing Device Sales by Type

2.3.1 Global Insulin Dosing Device Sales Market Share by Type (2017-2022)

2.3.2 Global Insulin Dosing Device Revenue and Market Share by Type (2017-2022)

2.3.3 Global Insulin Dosing Device Sale Price by Type (2017-2022)

2.4 Insulin Dosing Device Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Home Care

2.4.4 Others

2.5 Insulin Dosing Device Sales by Application

2.5.1 Global Insulin Dosing Device Sale Market Share by Application (2017-2022)

2.5.2 Global Insulin Dosing Device Revenue and Market Share by Application (2017-2022)

2.5.3 Global Insulin Dosing Device Sale Price by Application (2017-2022)

3 Global Insulin Dosing Device by Company

3.1 Global Insulin Dosing Device Breakdown Data by Company

3.1.1 Global Insulin Dosing Device Annual Sales by Company (2020-2022)

3.1.2 Global Insulin Dosing Device Sales Market Share by Company (2020-2022)

3.2 Global Insulin Dosing Device Annual Revenue by Company (2020-2022)

3.2.1 Global Insulin Dosing Device Revenue by Company (2020-2022)

3.2.2 Global Insulin Dosing Device Revenue Market Share by Company (2020-2022)

3.3 Global Insulin Dosing Device Sale Price by Company

3.4 Key Manufacturers Insulin Dosing Device Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Insulin Dosing Device Product Location Distribution

3.4.2 Players Insulin Dosing Device Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Insulin Dosing Device by Geographic Region

4.1 World Historic Insulin Dosing Device Market Size by Geographic Region (2017-2022)

4.1.1 Global Insulin Dosing Device Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Insulin Dosing Device Annual Revenue by Geographic Region

4.2 World Historic Insulin Dosing Device Market Size by Country/Region (2017-2022)

4.2.1 Global Insulin Dosing Device Annual Sales by Country/Region (2017-2022)

4.2.2 Global Insulin Dosing Device Annual Revenue by Country/Region

4.3 Americas Insulin Dosing Device Sales Growth

4.4 APAC Insulin Dosing Device Sales Growth

4.5 Europe Insulin Dosing Device Sales Growth

4.6 Middle East & Africa Insulin Dosing Device Sales Growth

5 Americas

5.1 Americas Insulin Dosing Device Sales by Country

5.1.1 Americas Insulin Dosing Device Sales by Country (2017-2022)

5.1.2 Americas Insulin Dosing Device Revenue by Country (2017-2022)

5.2 Americas Insulin Dosing Device Sales by Type

5.3 Americas Insulin Dosing Device Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Insulin Dosing Device Sales by Region

6.1.1 APAC Insulin Dosing Device Sales by Region (2017-2022)

6.1.2 APAC Insulin Dosing Device Revenue by Region (2017-2022)

6.2 APAC Insulin Dosing Device Sales by Type

6.3 APAC Insulin Dosing Device Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Insulin Dosing Device by Country

7.1.1 Europe Insulin Dosing Device Sales by Country (2017-2022)

7.1.2 Europe Insulin Dosing Device Revenue by Country (2017-2022)

7.2 Europe Insulin Dosing Device Sales by Type

7.3 Europe Insulin Dosing Device Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Insulin Dosing Device by Country

8.1.1 Middle East & Africa Insulin Dosing Device Sales by Country (2017-2022)

8.1.2 Middle East & Africa Insulin Dosing Device Revenue by Country (2017-2022)

8.2 Middle East & Africa Insulin Dosing Device Sales by Type

8.3 Middle East & Africa Insulin Dosing Device Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Insulin Dosing Device

10.3 Manufacturing Process Analysis of Insulin Dosing Device

10.4 Industry Chain Structure of Insulin Dosing Device

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Insulin Dosing Device Distributors

11.3 Insulin Dosing Device Customer

12 World Forecast Review for Insulin Dosing Device by Geographic Region

12.1 Global Insulin Dosing Device Market Size Forecast by Region

12.1.1 Global Insulin Dosing Device Forecast by Region (2023-2028)

12.1.2 Global Insulin Dosing Device Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Insulin Dosing Device Forecast by Type

12.7 Global Insulin Dosing Device Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Insulin Dosing Device Product Offered

13.1.3 Novo Nordisk Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Insulin Dosing Device Product Offered

13.2.3 Sanofi Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 BD

13.3.1 BD Company Information

13.3.2 BD Insulin Dosing Device Product Offered

13.3.3 BD Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BD Main Business Overview

13.3.5 BD Latest Developments

13.4 Eli Lilly

13.4.1 Eli Lilly Company Information

13.4.2 Eli Lilly Insulin Dosing Device Product Offered

13.4.3 Eli Lilly Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eli Lilly Main Business Overview

13.4.5 Eli Lilly Latest Developments

13.5 Medtronic

13.5.1 Medtronic Company Information

13.5.2 Medtronic Insulin Dosing Device Product Offered

13.5.3 Medtronic Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Medtronic Main Business Overview

13.5.5 Medtronic Latest Developments

13.6 Beta Bionics

13.6.1 Beta Bionics Company Information

13.6.2 Beta Bionics Insulin Dosing Device Product Offered

13.6.3 Beta Bionics Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Beta Bionics Main Business Overview

13.6.5 Beta Bionics Latest Developments

13.7 Copernicus

13.7.1 Copernicus Company Information

13.7.2 Copernicus Insulin Dosing Device Product Offered

13.7.3 Copernicus Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Copernicus Main Business Overview

13.7.5 Copernicus Latest Developments

13.8 Dance Biopharm

13.8.1 Dance Biopharm Company Information

13.8.2 Dance Biopharm Insulin Dosing Device Product Offered

13.8.3 Dance Biopharm Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Dance Biopharm Main Business Overview

13.8.5 Dance Biopharm Latest Developments

13.9 Debiotech

13.9.1 Debiotech Company Information

13.9.2 Debiotech Insulin Dosing Device Product Offered

13.9.3 Debiotech Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Debiotech Main Business Overview

13.9.5 Debiotech Latest Developments

13.10 Insulet

13.10.1 Insulet Company Information

13.10.2 Insulet Insulin Dosing Device Product Offered

13.10.3 Insulet Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Insulet Main Business Overview

13.10.5 Insulet Latest Developments

13.11 MannKind

13.11.1 MannKind Company Information

13.11.2 MannKind Insulin Dosing Device Product Offered

13.11.3 MannKind Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 MannKind Main Business Overview

13.11.5 MannKind Latest Developments

13.12 Owen Mumford

13.12.1 Owen Mumford Company Information

13.12.2 Owen Mumford Insulin Dosing Device Product Offered

13.12.3 Owen Mumford Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Owen Mumford Main Business Overview

13.12.5 Owen Mumford Latest Developments

13.13 Roche

13.13.1 Roche Company Information

13.13.2 Roche Insulin Dosing Device Product Offered

13.13.3 Roche Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Roche Main Business Overview

13.13.5 Roche Latest Developments

13.14 SOOIL

13.14.1 SOOIL Company Information

13.14.2 SOOIL Insulin Dosing Device Product Offered

13.14.3 SOOIL Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 SOOIL Main Business Overview

13.14.5 SOOIL Latest Developments

13.15 Tandem Diabetes Care

13.15.1 Tandem Diabetes Care Company Information

13.15.2 Tandem Diabetes Care Insulin Dosing Device Product Offered

13.15.3 Tandem Diabetes Care Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Tandem Diabetes Care Main Business Overview

13.15.5 Tandem Diabetes Care Latest Developments

13.16 Valeritas

13.16.1 Valeritas Company Information

13.16.2 Valeritas Insulin Dosing Device Product Offered

13.16.3 Valeritas Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Valeritas Main Business Overview

13.16.5 Valeritas Latest Developments

13.17 West Pharma

13.17.1 West Pharma Company Information

13.17.2 West Pharma Insulin Dosing Device Product Offered

13.17.3 West Pharma Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 West Pharma Main Business Overview

13.17.5 West Pharma Latest Developments

13.18 Ypsomed

13.18.1 Ypsomed Company Information

13.18.2 Ypsomed Insulin Dosing Device Product Offered

13.18.3 Ypsomed Insulin Dosing Device Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Ypsomed Main Business Overview

13.18.5 Ypsomed Latest Developments

14 Research Findings and Conclusion

Table 1. Insulin Dosing Device Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Insulin Dosing Device Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Insulin Pens

Table 4. Major Players of Insulin Pumps

Table 5. Major Players of Insulin Syringes

Table 6. Major Players of Others

Table 7. Global Insulin Dosing Device Sales by Type (2017-2022) & (K Units)

Table 8. Global Insulin Dosing Device Sales Market Share by Type (2017-2022)

Table 9. Global Insulin Dosing Device Revenue by Type (2017-2022) & ($ million)

Table 10. Global Insulin Dosing Device Revenue Market Share by Type (2017-2022)

Table 11. Global Insulin Dosing Device Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Insulin Dosing Device Sales by Application (2017-2022) & (K Units)

Table 13. Global Insulin Dosing Device Sales Market Share by Application (2017-2022)

Table 14. Global Insulin Dosing Device Revenue by Application (2017-2022)

Table 15. Global Insulin Dosing Device Revenue Market Share by Application (2017-2022)

Table 16. Global Insulin Dosing Device Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Insulin Dosing Device Sales by Company (2020-2022) & (K Units)

Table 18. Global Insulin Dosing Device Sales Market Share by Company (2020-2022)

Table 19. Global Insulin Dosing Device Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Insulin Dosing Device Revenue Market Share by Company (2020-2022)

Table 21. Global Insulin Dosing Device Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Insulin Dosing Device Producing Area Distribution and Sales Area

Table 23. Players Insulin Dosing Device Products Offered

Table 24. Insulin Dosing Device Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Insulin Dosing Device Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Insulin Dosing Device Sales Market Share Geographic Region (2017-2022)

Table 29. Global Insulin Dosing Device Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Insulin Dosing Device Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Insulin Dosing Device Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Insulin Dosing Device Sales Market Share by Country/Region (2017-2022)

Table 33. Global Insulin Dosing Device Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Insulin Dosing Device Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Insulin Dosing Device Sales by Country (2017-2022) & (K Units)

Table 36. Americas Insulin Dosing Device Sales Market Share by Country (2017-2022)

Table 37. Americas Insulin Dosing Device Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Insulin Dosing Device Revenue Market Share by Country (2017-2022)

Table 39. Americas Insulin Dosing Device Sales by Type (2017-2022) & (K Units)

Table 40. Americas Insulin Dosing Device Sales Market Share by Type (2017-2022)

Table 41. Americas Insulin Dosing Device Sales by Application (2017-2022) & (K Units)

Table 42. Americas Insulin Dosing Device Sales Market Share by Application (2017-2022)

Table 43. APAC Insulin Dosing Device Sales by Region (2017-2022) & (K Units)

Table 44. APAC Insulin Dosing Device Sales Market Share by Region (2017-2022)

Table 45. APAC Insulin Dosing Device Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Insulin Dosing Device Revenue Market Share by Region (2017-2022)

Table 47. APAC Insulin Dosing Device Sales by Type (2017-2022) & (K Units)

Table 48. APAC Insulin Dosing Device Sales Market Share by Type (2017-2022)

Table 49. APAC Insulin Dosing Device Sales by Application (2017-2022) & (K Units)

Table 50. APAC Insulin Dosing Device Sales Market Share by Application (2017-2022)

Table 51. Europe Insulin Dosing Device Sales by Country (2017-2022) & (K Units)

Table 52. Europe Insulin Dosing Device Sales Market Share by Country (2017-2022)

Table 53. Europe Insulin Dosing Device Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Insulin Dosing Device Revenue Market Share by Country (2017-2022)

Table 55. Europe Insulin Dosing Device Sales by Type (2017-2022) & (K Units)

Table 56. Europe Insulin Dosing Device Sales Market Share by Type (2017-2022)

Table 57. Europe Insulin Dosing Device Sales by Application (2017-2022) & (K Units)

Table 58. Europe Insulin Dosing Device Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Insulin Dosing Device Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Insulin Dosing Device Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Insulin Dosing Device Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Insulin Dosing Device Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Insulin Dosing Device Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Insulin Dosing Device Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Insulin Dosing Device Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Insulin Dosing Device Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Insulin Dosing Device

Table 68. Key Market Challenges & Risks of Insulin Dosing Device

Table 69. Key Industry Trends of Insulin Dosing Device

Table 70. Insulin Dosing Device Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Insulin Dosing Device Distributors List

Table 73. Insulin Dosing Device Customer List

Table 74. Global Insulin Dosing Device Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Insulin Dosing Device Sales Market Forecast by Region

Table 76. Global Insulin Dosing Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Insulin Dosing Device Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Insulin Dosing Device Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Insulin Dosing Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Insulin Dosing Device Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Insulin Dosing Device Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Insulin Dosing Device Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Insulin Dosing Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Insulin Dosing Device Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Insulin Dosing Device Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Insulin Dosing Device Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Insulin Dosing Device Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Insulin Dosing Device Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Insulin Dosing Device Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Insulin Dosing Device Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Insulin Dosing Device Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Insulin Dosing Device Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Insulin Dosing Device Revenue Market Share Forecast by Application (2023-2028)

Table 94. Novo Nordisk Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 95. Novo Nordisk Insulin Dosing Device Product Offered

Table 96. Novo Nordisk Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Novo Nordisk Main Business

Table 98. Novo Nordisk Latest Developments

Table 99. Sanofi Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 100. Sanofi Insulin Dosing Device Product Offered

Table 101. Sanofi Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Sanofi Main Business

Table 103. Sanofi Latest Developments

Table 104. BD Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 105. BD Insulin Dosing Device Product Offered

Table 106. BD Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. BD Main Business

Table 108. BD Latest Developments

Table 109. Eli Lilly Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 110. Eli Lilly Insulin Dosing Device Product Offered

Table 111. Eli Lilly Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Eli Lilly Main Business

Table 113. Eli Lilly Latest Developments

Table 114. Medtronic Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 115. Medtronic Insulin Dosing Device Product Offered

Table 116. Medtronic Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Medtronic Main Business

Table 118. Medtronic Latest Developments

Table 119. Beta Bionics Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 120. Beta Bionics Insulin Dosing Device Product Offered

Table 121. Beta Bionics Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Beta Bionics Main Business

Table 123. Beta Bionics Latest Developments

Table 124. Copernicus Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 125. Copernicus Insulin Dosing Device Product Offered

Table 126. Copernicus Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Copernicus Main Business

Table 128. Copernicus Latest Developments

Table 129. Dance Biopharm Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 130. Dance Biopharm Insulin Dosing Device Product Offered

Table 131. Dance Biopharm Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Dance Biopharm Main Business

Table 133. Dance Biopharm Latest Developments

Table 134. Debiotech Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 135. Debiotech Insulin Dosing Device Product Offered

Table 136. Debiotech Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Debiotech Main Business

Table 138. Debiotech Latest Developments

Table 139. Insulet Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 140. Insulet Insulin Dosing Device Product Offered

Table 141. Insulet Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Insulet Main Business

Table 143. Insulet Latest Developments

Table 144. MannKind Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 145. MannKind Insulin Dosing Device Product Offered

Table 146. MannKind Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. MannKind Main Business

Table 148. MannKind Latest Developments

Table 149. Owen Mumford Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 150. Owen Mumford Insulin Dosing Device Product Offered

Table 151. Owen Mumford Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Owen Mumford Main Business

Table 153. Owen Mumford Latest Developments

Table 154. Roche Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 155. Roche Insulin Dosing Device Product Offered

Table 156. Roche Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Roche Main Business

Table 158. Roche Latest Developments

Table 159. SOOIL Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 160. SOOIL Insulin Dosing Device Product Offered

Table 161. SOOIL Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. SOOIL Main Business

Table 163. SOOIL Latest Developments

Table 164. Tandem Diabetes Care Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 165. Tandem Diabetes Care Insulin Dosing Device Product Offered

Table 166. Tandem Diabetes Care Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Tandem Diabetes Care Main Business

Table 168. Tandem Diabetes Care Latest Developments

Table 169. Valeritas Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 170. Valeritas Insulin Dosing Device Product Offered

Table 171. Valeritas Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Valeritas Main Business

Table 173. Valeritas Latest Developments

Table 174. West Pharma Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 175. West Pharma Insulin Dosing Device Product Offered

Table 176. West Pharma Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. West Pharma Main Business

Table 178. West Pharma Latest Developments

Table 179. Ypsomed Basic Information, Insulin Dosing Device Manufacturing Base, Sales Area and Its Competitors

Table 180. Ypsomed Insulin Dosing Device Product Offered

Table 181. Ypsomed Insulin Dosing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. Ypsomed Main Business

Table 183. Ypsomed Latest Developments

List of Figures

Figure 1. Picture of Insulin Dosing Device

Figure 2. Insulin Dosing Device Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Insulin Dosing Device Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Insulin Dosing Device Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Insulin Dosing Device Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Insulin Pens

Figure 10. Product Picture of Insulin Pumps

Figure 11. Product Picture of Insulin Syringes

Figure 12. Product Picture of Others

Figure 13. Global Insulin Dosing Device Sales Market Share by Type in 2021

Figure 14. Global Insulin Dosing Device Revenue Market Share by Type (2017-2022)

Figure 15. Insulin Dosing Device Consumed in Hospital

Figure 16. Global Insulin Dosing Device Market: Hospital (2017-2022) & (K Units)

Figure 17. Insulin Dosing Device Consumed in Clinic

Figure 18. Global Insulin Dosing Device Market: Clinic (2017-2022) & (K Units)

Figure 19. Insulin Dosing Device Consumed in Home Care

Figure 20. Global Insulin Dosing Device Market: Home Care (2017-2022) & (K Units)

Figure 21. Insulin Dosing Device Consumed in Others

Figure 22. Global Insulin Dosing Device Market: Others (2017-2022) & (K Units)

Figure 23. Global Insulin Dosing Device Sales Market Share by Application (2017-2022)

Figure 24. Global Insulin Dosing Device Revenue Market Share by Application in 2021

Figure 25. Insulin Dosing Device Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Insulin Dosing Device Revenue Market Share by Company in 2021

Figure 27. Global Insulin Dosing Device Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Insulin Dosing Device Revenue Market Share by Geographic Region in 2021

Figure 29. Global Insulin Dosing Device Sales Market Share by Region (2017-2022)

Figure 30. Global Insulin Dosing Device Revenue Market Share by Country/Region in 2021

Figure 31. Americas Insulin Dosing Device Sales 2017-2022 (K Units)

Figure 32. Americas Insulin Dosing Device Revenue 2017-2022 ($ Millions)

Figure 33. APAC Insulin Dosing Device Sales 2017-2022 (K Units)

Figure 34. APAC Insulin Dosing Device Revenue 2017-2022 ($ Millions)

Figure 35. Europe Insulin Dosing Device Sales 2017-2022 (K Units)

Figure 36. Europe Insulin Dosing Device Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Insulin Dosing Device Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Insulin Dosing Device Revenue 2017-2022 ($ Millions)

Figure 39. Americas Insulin Dosing Device Sales Market Share by Country in 2021

Figure 40. Americas Insulin Dosing Device Revenue Market Share by Country in 2021

Figure 41. United States Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Insulin Dosing Device Sales Market Share by Region in 2021

Figure 46. APAC Insulin Dosing Device Revenue Market Share by Regions in 2021

Figure 47. China Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Insulin Dosing Device Sales Market Share by Country in 2021

Figure 54. Europe Insulin Dosing Device Revenue Market Share by Country in 2021

Figure 55. Germany Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Insulin Dosing Device Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Insulin Dosing Device Revenue Market Share by Country in 2021

Figure 62. Egypt Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Insulin Dosing Device Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Insulin Dosing Device in 2021

Figure 68. Manufacturing Process Analysis of Insulin Dosing Device

Figure 69. Industry Chain Structure of Insulin Dosing Device

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles